This company has been marked as potentially delisted and may not be actively trading. Third Harmonic Bio (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock THRD vs. BGM, NEO, PRAX, SION, NAGE, SYRE, PHVS, NRIX, MLYS, and RCUSShould you be buying Third Harmonic Bio stock or one of its competitors? The main competitors of Third Harmonic Bio include BGM Group (BGM), NeoGenomics (NEO), Praxis Precision Medicines (PRAX), Sionna Therapeutics (SION), Niagen Bioscience (NAGE), Spyre Therapeutics (SYRE), Pharvaris (PHVS), Nurix Therapeutics (NRIX), Mineralys Therapeutics (MLYS), and Arcus Biosciences (RCUS). These companies are all part of the "med - biomed/gene" industry. Third Harmonic Bio vs. Its Competitors BGM Group NeoGenomics Praxis Precision Medicines Sionna Therapeutics Niagen Bioscience Spyre Therapeutics Pharvaris Nurix Therapeutics Mineralys Therapeutics Arcus Biosciences Third Harmonic Bio (NASDAQ:THRD) and BGM Group (NASDAQ:BGM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability. Is THRD or BGM more profitable? BGM Group's return on equity of 0.00% beat Third Harmonic Bio's return on equity.Company Net Margins Return on Equity Return on Assets Third Harmonic BioN/A -19.27% -18.67% BGM Group N/A N/A N/A Which has higher earnings and valuation, THRD or BGM? BGM Group has higher revenue and earnings than Third Harmonic Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThird Harmonic BioN/AN/A-$45.47M-$0.62-8.79BGM Group$25.10M36.06-$1.44MN/AN/A Which has more volatility and risk, THRD or BGM? Third Harmonic Bio has a beta of 2.12, suggesting that its stock price is 112% more volatile than the S&P 500. Comparatively, BGM Group has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Do analysts prefer THRD or BGM? Third Harmonic Bio presently has a consensus price target of $5.00, suggesting a potential downside of 8.26%. Given Third Harmonic Bio's stronger consensus rating and higher probable upside, research analysts plainly believe Third Harmonic Bio is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Third Harmonic Bio 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor THRD or BGM? In the previous week, Third Harmonic Bio had 1 more articles in the media than BGM Group. MarketBeat recorded 3 mentions for Third Harmonic Bio and 2 mentions for BGM Group. BGM Group's average media sentiment score of 0.44 beat Third Harmonic Bio's score of 0.00 indicating that BGM Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Third Harmonic Bio 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BGM Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in THRD or BGM? 94.0% of Third Harmonic Bio shares are owned by institutional investors. 5.9% of Third Harmonic Bio shares are owned by insiders. Comparatively, 58.7% of BGM Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryBGM Group beats Third Harmonic Bio on 6 of the 11 factors compared between the two stocks. Get Third Harmonic Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding THRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricThird Harmonic BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$245.95M$2.94B$5.55B$9.09BDividend YieldN/A2.45%5.07%4.03%P/E RatioN/A20.8528.2520.32Price / SalesN/A291.87431.56110.05Price / CashN/A41.0526.2427.98Price / Book0.867.638.125.50Net Income-$45.47M-$55.05M$3.19B$250.38M Third Harmonic Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDThird Harmonic Bio0.2825 of 5 stars$5.45flat$5.00-8.3%-58.0%$245.95MN/A0.00N/ABGMBGM GroupN/A$9.93-0.7%N/AN/A$965.40M$25.10M0.00298Gap UpNEONeoGenomics3.6803 of 5 stars$7.45+1.9%$13.83+85.7%-50.9%$958.78M$672.36M-12.212,200PRAXPraxis Precision Medicines2.4382 of 5 stars$46.76+0.2%$94.11+101.3%-0.7%$952.50M$8.55M-4.36110Analyst ForecastSIONSionna TherapeuticsN/A$21.57+2.9%$38.50+78.5%N/A$951.67MN/A0.0035Positive NewsNAGENiagen Bioscience1.3423 of 5 stars$11.97-3.8%$19.50+62.9%N/A$942.88M$99.60M70.41120SYRESpyre Therapeutics1.9973 of 5 stars$15.61+2.0%$53.40+242.1%-47.1%$940.97M$890K-4.1473Positive NewsPHVSPharvaris1.5268 of 5 stars$17.98-0.1%$36.20+101.3%+33.8%$940.17MN/A-5.9730News CoverageNRIXNurix Therapeutics1.5597 of 5 stars$12.21-1.2%$30.18+147.1%-47.8%$930.89M$54.55M-4.36300Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownMLYSMineralys Therapeutics2.3624 of 5 stars$13.95+3.1%$32.25+131.2%+0.1%$909.26MN/A-3.7428RCUSArcus Biosciences2.1281 of 5 stars$8.53+3.8%$21.29+149.5%-38.1%$903.24M$258M-2.04500 Related Companies and Tools Related Companies BGM Group Competitors NeoGenomics Competitors Praxis Precision Medicines Competitors Sionna Therapeutics Competitors Niagen Bioscience Competitors Spyre Therapeutics Competitors Pharvaris Competitors Nurix Therapeutics Competitors Mineralys Therapeutics Competitors Arcus Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THRD) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THRD Stock Alerts